CMPI Historical PE Ratio image   This CMPI PE ratio history page last updated 5/16/2022
CMPI PE History Chart
PeriodPriceGAAPTTMPE
Q1 2022
5/12/2022
10.43-0.73-2.92NA
Q4 2021
3/29/2022
3.21-0.62-2.84NA
Q3 2021
11/12/2021
4.25-0.69-0.92NA
Q2 2021
8/12/2021
5.30-0.88-1.07NA
Q1 2021
5/13/2021
6.17-0.65-7.56NA
Q4 2020
3/29/2021
10.791.30NANA
Q3 2020
11/13/2020
10.70-0.84NANA
Q2 2020
9/18/2020
10.67-7.37NANA
CMPI Historical PE Ratio Chart
Data adjusted for CMPI split history

PeriodPriceGAAPAnnualizedPE
Q1 2022
5/12/2022
10.43-0.73-2.92NA
Q4 2021
3/29/2022
3.21-0.62-2.48NA
Q3 2021
11/12/2021
4.25-0.69-2.76NA
Q2 2021
8/12/2021
5.30-0.88-3.52NA
Q1 2021
5/13/2021
6.17-0.65-2.60NA
Q4 2020
3/29/2021
10.791.305.202.1
Q3 2020
11/13/2020
10.70-0.84-3.36NA
Q2 2020
9/18/2020
10.67-7.37-29.48NA
Quotes delayed 20 minutes

Email EnvelopeFree CMPI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Checkmate Pharmaceuticals (CMPI) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CMPX PE Ratio History
CMRX PE Ratio History
CNC PE Ratio History
CNCE PE Ratio History
CNMD PE Ratio History
CNSP PE Ratio History
CNST PE Ratio History
CNTX PE Ratio History
CNVY PE Ratio History
COCP PE Ratio History
On this page we presented the CMPI PE Ratio History information for Checkmate Pharmaceuticals' stock. The average CMPI PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 2.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CMPI PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CMPI PE ratio history result, against the recent PE: when this page was posted on 5/13/2022, the most recent closing price for CMPI had been 10.44, and the most recent quarterly earnings result, annualized, was 5.2. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent CMPI PE on 5/13/2022 based on annualized quarterly EPS was 2.0. Based on CMPI's history, that recent PE is low relative to the historical average, with the recent PE 4.8% lower than the historical average PE across our data set for Checkmate Pharmaceuticals.

For self directed investors doing their due diligence on CMPI or any other given stock, valuation analysis for CMPI can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Checkmate Pharmaceuticals PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for CMPI. Thanks for visiting, and the next time you need to research CMPI PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: CNO shares outstanding history, CHRS Average Annual Return, LRN market cap history.

 

CMPI PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.